Fagron N.V.
General ticker "ARSUF" information:
- Sector: Health Care
- Industry: Drug Manufacturers - Specialty & Generic
- Capitalization: $1.6B (TTM average)
Fagron N.V. follows the US Stock Market performance with the rate: 36.3%.
Estimated limits based on current volatility of 0.1%: low 26.99$, high 27.04$
Factors to consider:
- Company pays dividends (annually): last record date 2025-05-20, amount 0.39$ (Y1.44%)
Short-term ARSUF quotes
Long-term ARSUF plot
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | €762.99MM | €871.96MM | €951.81MM |
| Operating Expenses | €654.36MM | €741.26MM | €805.66MM |
| Operating Income | €108.63MM | €130.70MM | €146.16MM |
| Non-Operating Income | €-24.19MM | €-26.40MM | €-28.61MM |
| Interest Expense | €22.98MM | €26.57MM | €32.67MM |
| R&D Expense | €2.70MM | €0.00MM | €0.00MM |
| Income(Loss) | €84.44MM | €104.30MM | €117.55MM |
| Taxes | €13.40MM | €23.30MM | €26.06MM |
| Profit(Loss)* | €70.55MM | €80.55MM | €90.99MM |
| Stockholders Equity | €463.75MM | €501.35MM | €551.40MM |
| Inventory | €113.94MM | €136.96MM | €158.85MM |
| Assets | €1,006.95MM | €1,083.52MM | €1,242.66MM |
| Operating Cash Flow | €124.63MM | €109.89MM | €128.23MM |
| Capital expenditure | €38.47MM | €40.80MM | €15.25MM |
| Investing Cash Flow | €-44.76MM | €-69.74MM | €-100.32MM |
| Financing Cash Flow | €-74.28MM | €-54.01MM | €46.50MM |
| Earnings Per Share** | €0.97 | €1.10 | €1.25 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.